Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
about
Hepatitis B and human immunodeficiency virus co-infectionThe Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the LiteratureClinical impact of occult hepatitis B virus infection in immunosuppressed patientsMaternal hepatitis B and infant infection among pregnant women living with HIV in South Africa.Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern IndiaHepatitis B and long-term HIV outcomes in coinfected HAART recipients.Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapyOccult hepatitis B virus infection among Mexican human immunodeficiency virus-1-infected patients.Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: high prevalence of occult hepatitis B and F3 subgenotype dominancePrevalence of occult hepatitis B virus infectionManagement of occult hepatitis B virus infection: an update for the clinician.Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals.Occult hepatitis B virus infection: A major concern in HIV-infected patients: Occult HBV in HIV.Occult HBV infection.Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study.Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C CoinfectionHepatitis B virus (HBV)-specific T-cell responses to recombinant HBV core protein in patients with normal liver function and co-infected with chronic HBV and human immunodeficiency virus 1 (HIV-1)Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in NigeriaFuture directions in the treatment of HIV-HBV coinfection.Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.Liver Fibrosis and Hepatitis B Coinfection among ART Naïve HIV-Infected Patients at a Tertiary Level Hospital in Northwestern Tanzania: A Cross-Sectional StudyVaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study.Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study.Prevalence of occult hepatitis B virus infection in a cohort of HIV-positive patients resident in Sicily, Italy.High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana.Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa.Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana.Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumptionOccult Hepatitis B Infection in the Immigrant Population of Sicily, Italy
P2860
Q26822862-C48AD0D3-FB5B-44F0-ABF3-972F230C4683Q26864344-6576B670-839F-4390-9E17-6DB6DA1E7999Q27006996-5281A15D-8202-4E43-875A-9306B1492532Q33655929-58169CC3-C17C-4439-A527-8BE0354805B3Q33773235-D3850E63-F42D-4B0A-8CD9-913F2031ADA6Q33819311-05A97EE9-0639-4142-B6EA-0AF1B68A6EC5Q34067400-4585DD59-D80A-4405-BBC4-A2A3BB4E1859Q34303032-5CE5A0FB-9F61-4DE1-BFEB-3838922A2D4AQ34437586-20118511-706A-4320-BA73-E6D3C46E53C2Q34612595-C906922A-E95A-4F73-8C79-C6CE89E9DB10Q34757367-00F88335-7F3D-4DC1-9A09-49D70CD61597Q34757408-E388E1F7-C2AE-47CF-AAB6-245747A382FEQ34831090-6C4FB27E-828D-44D6-8842-F2A3D5A1136DQ35507274-256B5321-F2D0-4EF8-93FA-FBBB64FDA8DEQ36518847-1BDDE7B2-2D62-487B-8D86-0180D6A801CEQ36555268-A765BE78-1709-402A-BA13-CDF1928B38E8Q37014002-236DCAEB-A197-4A28-B2C1-6A386CFFFB76Q37033272-0C55D63C-66B7-4487-8376-D3A3CD0D760CQ37366842-C46F0953-BD19-4686-9E31-90AD3CB1E2CFQ37439933-4A3E3860-1498-464D-BCE1-53652E8BFA45Q37686490-1DDF5E45-2B59-4413-9CF1-FE843FA4C907Q38615081-28CA0D3D-8365-409D-93A2-21AFA5160D26Q40107327-B3607F5A-F43D-4FA0-A0A1-6316BA7F4D7BQ40528258-C77F8F7A-9B98-4218-90C1-336EBABF9901Q42220626-287D2AC3-F72A-4D28-971D-8774DAEB6271Q42267396-51409196-9D31-4F6A-95D2-ABB01F231675Q42698618-3482D98E-4B33-4208-B567-099EB71D862BQ43036160-36DE1D63-5BA6-454C-AD8E-8D30A63674D9Q45361628-39FB4E8F-3EC8-40D9-AA7A-1A420B619CA1Q45365130-A95B68E7-DBBC-4F35-B725-3130BAFC2F7EQ55030278-231DB15D-23A4-4ADD-982D-3DB41A79A3ABQ58290827-5D2A4C3A-F56C-4DF2-946F-CCBA3DD5BBF5Q59127531-CCA0EDE1-34A2-4BC9-A6F3-CD56F86DD2C3
P2860
Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Occult hepatitis B in persons ...... during antiretroviral therapy.
@en
Occult hepatitis B in persons ...... during antiretroviral therapy.
@nl
type
label
Occult hepatitis B in persons ...... during antiretroviral therapy.
@en
Occult hepatitis B in persons ...... during antiretroviral therapy.
@nl
prefLabel
Occult hepatitis B in persons ...... during antiretroviral therapy.
@en
Occult hepatitis B in persons ...... during antiretroviral therapy.
@nl
P2093
P356
P1476
Occult hepatitis B in persons ...... during antiretroviral therapy
@en
P2093
Andy I M Hoepelman
Charles A B Boucher
James W T Cohen Stuart
Rob Schuurman
P304
P356
10.1002/JMV.21422
P577
2009-03-01T00:00:00Z